THE PNPLA3 I148M VARIANT INITIATES METABOLIC REPROGRAMMING IN MACROPHAGES

被引：0

作者：

Dixon, Emmanuel ^{[1
]}

Claudel, Thierry ^{[1
]}

Genger, Jakob-Wendelin ^{[1
]}

Zhu, Ci ^{[1
]}

Stadlmayr, Sarah ^{[1
]}

Paolini, Erika ^{[2
]}

Nardo, Alexander ^{[1
]}

Mlitz, Veronika ^{[1
]}

Fuchs, Claudia ^{[1
]}

Bergthaler, Andreas ^{[1
]}

Dongiovanni, Paola ^{[2
]}

Ellmeier, Wilfried ^{[1
]}

Trauner, Michael ^{[1
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Med Univ Milan, Milan, Italy

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2629

引用

页码：S1990 / S1991

页数：2

共 50 条

[31] Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population
Li, Yiling
Xing, Chao
Tian, Zhong
Ku, Hung-Chih
BMC MEDICAL GENETICS, 2012, 13
[32] A DISTINCT MIRNA EXPRESSION PROFILE IN HEPATOCELLULAR CARCINOMA ARISING IN CARRIERS OF THE I148M PNPLA3 GENE VARIANT
Donati, B.
Vaira, V.
Donnangelo, A.
Maggioni, M.
Augello, C.
Dongiovanni, P.
Milano, M.
Roncalli, M.
Fargion, S.
Bosari, S.
Valenti, L.
DIGESTIVE AND LIVER DISEASE, 2015, 47 : E233 - E233
[33] I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders
Xia, M. -F.
Ling, Y.
Bian, H.
Lin, H. -D.
Yan, H. -M.
Chang, X. -X.
Li, X. -M.
Ma, H.
Wang, D.
Zhang, L. -S.
Wang, S. -S.
Wu, B. -J.
He, W. -Y.
Zhao, N. -Q.
Gao, X.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) : 631 - 642
[34] Association of Bright Liver With the PNPLA3 I148M Gene Variant in 1-Year-Old Toddlers
Bedogni, Giorgio
De Matteis, Giuseppe
Fabrizi, Marta
Alisi, Anna
Crudele, Annalisa
Pizzolante, Fabrizio
Signore, Fabrizio
Dallapiccola, Bruno
Nobili, Valerio
Manco, Melania
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (06): : 2163 - 2170
[35] RETRACTED: I148M PNPLA3 Variant and Progressive Liver Disease: A New Paradigm in Hepatology (Retracted Article)
Valenti, Luca
Alisi, Anna
Nobili, Valerio
HEPATOLOGY, 2012, 56 (02)
[36] I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders
Xia, Mingfeng
Ling, Yan
Lin, Huandong
Yan, Hongmei
Chang, Xinxia
Zhang, Linshan
Gao, Xin
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 9 - 10
[37] I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease
Park, Jin-Ho
Cho, BeLong
Kwon, Hyuktae
Prilutsky, Daria
Yun, Jae Moon
Choi, Ho Chun
Hwang, Kyu-Baek
Lee, In-Hee
Kim, Jong-Il
Kong, Sek Won
LIVER INTERNATIONAL, 2015, 35 (12) : 2537 - 2546
[38] Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity
Hyysalo, Jenni
Gopalacharyulu, Peddinti
Bian, Hua
Hyotylainen, Tuulia
Leivonen, Marja
Jaser, Nabil
Juuti, Anne
Honka, Miikka-Juhani
Nuutila, Pirjo
Olkkonen, Vesa M.
Oresic, Matej
Yki-Jarvinen, Hannele
DIABETES, 2014, 63 (01) : 312 - 322
[39] Genetic variant I148M in PNPLA3 is associated with acoustic radiation force impulse imaging in patients with NAFLD
Yoshioka, Kentaro
Shimazaki, Hiroaki
Kawabe, Naoto
Harata, Masao
Nitta, Yoshifumi
Murao, Michihito
Nakano, Takuji
Arima, Yuko
Kan, Toshiki
Ohki, Masashi
Nakaoka, Kazunori
Yuka, Takagawa
Nishikawa, Toru
Osakabe, Keisuke
Ichino, Naohiro
Hashimoto, Senju
HEPATOLOGY, 2013, 58 : 480A - 480A
[40] Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance
Rametta, Raffaela
Ruscica, Massimiliano
Dongiovanni, Paola
Macchi, Chiara
Fracanzani, Anna L.
Steffani, Liliana
Fargion, Silvia
Magni, Paolo
Valenti, Luca
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (07) : 627 - 633

← 1 2 3 4 5 →